{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:4080"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:4080","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"A qualitative study investigating the attitudes of primary health care professionals and patients towards the use of a ‘polypill’ to prevent cardiovascular disease","abstract":"Background A ‘polypill’ containing blood pressure and cholesterol lowering drugs given to all people over a specific age could prevent up to 80% of cardiovascular events (primary prevention). It could also be given to those with cardiovascular disease who are already taking separate drugs (secondary prevention). Minimal monitoring would be required. Little is known about attitudes of primary health care professionals and patients to such a strategy: hence the aim of this study. Methods Semi-structured interviews were conducted with 16 primary health care professionals and 17 patients across Birmingham. The principles of grounded theory were used to guide sampling and analysis. Results Health care professionals and patients expressed low acceptance of the polypill for primary prevention because of concerns about medicalisation, adverse effects, evidence, titration, impact on health related behaviours and confidence in preventive health. There was greater acceptance regarding its use for secondary prevention due to its practicality. Minimal monitoring received much scepticism as it was believed side-effects, efficacy and compliance would go undetected and because most medications are monitored. Conclusions Implementing a polypill for primary prevention would require health care professionals and patients to be convinced of the potential benefits. However, regular monitoring may need to continue.","abstract_html":"Background A ‘polypill’ containing blood pressure and cholesterol lowering drugs given to all people over a specific age could prevent up to 80% of cardiovascular events (primary prevention). It could also be given to those with cardiovascular disease who are already taking separate drugs (secondary prevention). Minimal monitoring would be required. Little is known about attitudes of primary health care professionals and patients to such a strategy: hence the aim of this study. Methods Semi-structured interviews were conducted with 16 primary health care professionals and 17 patients across Birmingham. The principles of grounded theory were used to guide sampling and analysis. Results Health care professionals and patients expressed low acceptance of the polypill for primary prevention because of concerns about medicalisation, adverse effects, evidence, titration, impact on health related behaviours and confidence in preventive health. There was greater acceptance regarding its use for secondary prevention due to its practicality. Minimal monitoring received much scepticism as it was believed side-effects, efficacy and compliance would go undetected and because most medications are monitored. Conclusions Implementing a polypill for primary prevention would require health care professionals and patients to be convinced of the potential benefits. However, regular monitoring may need to continue.","abstract_has_math":false,"creators":["Virdee, Satnam Kaur"],"institution":"University of Birmingham","degree_name":"m_rs","degree_level":"m_rs","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2013,"date_issued":"2013-07","date_published":"2013-07","updated_at":"2026-11-19T09:27:33Z","subjects":["RA Public aspects of medicine"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/4080/1/Virdee13MRes.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A4080","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Virdee, Satnam Kaur"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2013-07"]},{"key":"dc:date.issued","label":"Date","values":["2013-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","School of Health and Population Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/4080/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["m_rs"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["m_rs"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RA Public aspects of medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/4080/1/Virdee13MRes.pdf","http://etheses.bham.ac.uk//id/eprint/4080/2/Decl_IS_Virdee13MRes.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Background A ‘polypill’ containing blood pressure and cholesterol lowering drugs given to all people over a specific age could prevent up to 80% of cardiovascular events (primary prevention). It could also be given to those with cardiovascular disease who are already taking separate drugs (secondary prevention). Minimal monitoring would be required. Little is known about attitudes of primary health care professionals and patients to such a strategy: hence the aim of this study. Methods Semi-structured interviews were conducted with 16 primary health care professionals and 17 patients across Birmingham. The principles of grounded theory were used to guide sampling and analysis. Results Health care professionals and patients expressed low acceptance of the polypill for primary prevention because of concerns about medicalisation, adverse effects, evidence, titration, impact on health related behaviours and confidence in preventive health. There was greater acceptance regarding its use for secondary prevention due to its practicality. Minimal monitoring received much scepticism as it was believed side-effects, efficacy and compliance would go undetected and because most medications are monitored. Conclusions Implementing a polypill for primary prevention would require health care professionals and patients to be convinced of the potential benefits. However, regular monitoring may need to continue."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["A qualitative study investigating the attitudes of primary health care professionals and patients towards the use of a ‘polypill’ to prevent cardiovascular disease"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Virdee, Satnam Kaur"],"dc:date":["2013-07"],"dc:date.issued":["2013-07"],"dc:description.abstract":["Background A ‘polypill’ containing blood pressure and cholesterol lowering drugs given to all people over a specific age could prevent up to 80% of cardiovascular events (primary prevention). It could also be given to those with cardiovascular disease who are already taking separate drugs (secondary prevention). Minimal monitoring would be required. Little is known about attitudes of primary health care professionals and patients to such a strategy: hence the aim of this study. Methods Semi-structured interviews were conducted with 16 primary health care professionals and 17 patients across Birmingham. The principles of grounded theory were used to guide sampling and analysis. Results Health care professionals and patients expressed low acceptance of the polypill for primary prevention because of concerns about medicalisation, adverse effects, evidence, titration, impact on health related behaviours and confidence in preventive health. There was greater acceptance regarding its use for secondary prevention due to its practicality. Minimal monitoring received much scepticism as it was believed side-effects, efficacy and compliance would go undetected and because most medications are monitored. Conclusions Implementing a polypill for primary prevention would require health care professionals and patients to be convinced of the potential benefits. However, regular monitoring may need to continue."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/4080/1/Virdee13MRes.pdf","http://etheses.bham.ac.uk//id/eprint/4080/2/Decl_IS_Virdee13MRes.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","School of Health and Population Sciences"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/4080/"],"dc:subject":["RA Public aspects of medicine"],"dcterms:accessrights":["public","staffonly"],"dc:title":["A qualitative study investigating the attitudes of primary health care professionals and patients towards the use of a ‘polypill’ to prevent cardiovascular disease"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["m_rs"],"dc:type.qualificationname":["m_rs"]},"updated_at":"2026-11-19T09:27:33Z"}